GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) » Definitions » Research & Development

Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) Research & Development : E£0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Macro Group Pharmaceuticals (Macro Capital) Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Macro Group Pharmaceuticals (Macro Capital) Co's Research & Development for the three months ended in Sep. 2024 was E£0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was E£0.0 Mil.

Macro Group Pharmaceuticals (Macro Capital) Co Research & Development Historical Data

The historical data trend for Macro Group Pharmaceuticals (Macro Capital) Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Macro Group Pharmaceuticals (Macro Capital) Co Research & Development Chart

Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend Dec20 Dec21 Dec22
Research & Development
- - -

Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Macro Group Pharmaceuticals (Macro Capital) Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Macro Group Pharmaceuticals (Macro Capital) Co  (CAI:MCRO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Macro Group Pharmaceuticals (Macro Capital) Co Research & Development Related Terms

Thank you for viewing the detailed overview of Macro Group Pharmaceuticals (Macro Capital) Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Macro Group Pharmaceuticals (Macro Capital) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) » Definitions » Research & Development
Comparable Companies
CAI:COSG PG XPAR:OR LSE:ULVR CL BOM:500696 KVUE KMB LSE:RKT XTER:HEN3 XTER:BEI CHD EL TSE:4452 OSTO:ESSITY B CLX TSE:8113 BOM:532424 BOM:531642 XMAD:PUIG
Traded in Other Exchanges
N/A
Address
83, Al Moltaka Al Arabi, Sheraton, Cairo, EGY
Website
https://www.macro-egy.com
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.

Macro Group Pharmaceuticals (Macro Capital) Co Headlines